Berger Montague is proud to announce that the Firm has been named the 2021 Elite Trial Lawyers Pharmaceutical Litigation Law Firm of the Year by the National Law Journal.
(July 30, 2021) The U.S. Securities and Exchange Commission (“SEC”) has identified a number of China-based companies raising capital through offshore shell companies. In a number sectors in China, companies are not allowed to have foreign ownership and cannot directly list on stock exchanges outside of China. Some of these […]
Berger Montague is proud to announce that Thomson Reuters has named Managing Shareholder E. Michelle Drake a 2021 Minnesota Super Lawyer. In addition, Associate John Albanese and Senior Counsel Hans Lodge have been named 2021 Minnesota Rising Stars.
Berger Montague’s Minneapolis and San Diego offices have moved to more convenient locations amidst growing demand for the Firm’s attorneys and services.
The national plaintiffs’ law firm Berger Montague has filed a class action lawsuit against Dutch medical equipment company Philips to protect consumers harmed by Philips’ recalled sleep apnea machines, including CPAP and BiPAP machines, and ventilators, which may increase users’ risk of cancer and pulmonary fibrosis, and cause other injuries such as headaches, irritation, inflammation, respiratory issues, and exposure to materials with toxic and carcinogenic effects. The case is Shelton v. Koninklijke Philips N.V., et al., No. 1:21-cv-11076 (D. Mass.).
For investors seeking quick—and virtually unrestricted—cash without having to sell their investments, securities-backed lines of credit (“SBLOC”) have emerged as an exceedingly popular option. The SBLOC concept is simple. For monthly interest-only payments, brokerage firms extend to investors a revolving line of credit that is collateralized against assets in the […]
(June 25, 2021) The Ontario Superior Court of Justice (Justice Morgan) certified a Class of investors that purchased Intellipharmaceutics International, Inc.’s securities (“IPCI”) listed on the Toronto Stock Exchange and scheduled a hearing date to approve a Settlement Agreement between investors and IPCI. The Plaintiffs allege that Intellipharm’s value and […]
Kajan Johnson and C.B. Dollaway, two long-time veterans of the Ultimate Fighting Championship (“UFC”), filed a proposed class action antitrust lawsuit against Zuffa, LLC (d/b/a Ultimate Fighting Championship and UFC) and its parent company Endeavor Group Holdings, Inc.
Berger Montague PC is pleased to announce that attorney Dena Young has joined the Firm’s Philadelphia office as Senior Counsel. Ms. Young is a talented, passionate, and proven litigator with a demonstrated record of achievement.
(June 16, 2021) The Ontario Superior Court of Justice has granted investors’ motion to allow them to proceed into discovery finding that there is a reasonable possibility that Auxly (“XLY”) released its 3Q 2018 MD&A with misrepresentations about its relationship with FSD Pharma Inc., (“HUGE”) and the status of the […]
Berger Montague is proud to announce that the Firm has been named a Tier 1 Law Firm in the Antitrust: Civil Litigation/Class Actions: Plaintiff division of The Legal 500 United States 2021.
Berger Montague is proud to announce that Law360 has named Shareholders Patrick F. Madden and Camille Fundora Rodriguez 2021 Rising Stars. They are two of only 180 attorneys to receive this honor.